Treatment of these
| Severity | Treatment |
|---|---|
| Mild-Moderate | Topical corticosteroids (mid-to-high potency) twice daily x 1-2 weeks |
| Small area, moderate | Superpotent TCS - clobetasol propionate or betamethasone dipropionate BD x 1-2 weeks |
| Maintenance/sensitive areas | Topical immunomodulators - tacrolimus (Protopic) or pimecrolimus (Elidel) |
| Indication | Drug |
|---|---|
| Severe/widespread ACD | Oral corticosteroids - prednisone (tapering course over minimum 2 weeks to prevent rebound) |
| Pruritus control | Antihistamines - hydroxyzine, diphenhydramine (sedating); loratadine, cetirizine, fexofenadine (non-sedating) |
Important: Systemic steroids should be continued for at least 2 weeks - stopping earlier risks rebound dermatitis.
| Feature | ICD | ACD |
|---|---|---|
| Mechanism | Direct toxicity | Type IV hypersensitivity |
| Treatment cornerstone | Avoidance + barrier | Avoidance + TCS |
| Topical steroids | Yes | Yes (1st line) |
| Systemic steroids | Rarely | For severe cases |
| Patch testing | Not needed | Yes - to identify allergen |
| Immunomodulators | Occasionally | Yes (tacrolimus/pimecrolimus) |